NR4A1 and breast cancer: Network pharmacology analysis further corroborated the therapeutic potential of the bioactive compounds in OT, demonstrating their ability to modulate dysregulated proteins involved in kinase signaling, cell survival, apoptosis regulation, and hormone receptor pathways for alleviating BC development.